 |
|
Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension
Byung Ju Kang, Yeon-Mok Oh, Sang-Do Lee, Jae Seung Lee
Korean J Intern Med. 2015;30(6):837-845. Published online 2015 Oct 30 DOI: https://doi.org/10.3904/kjim.2015.30.6.837
|
|
Citations to this article as recorded by
 The role of anticoagulation on the long-term survival of patients with pulmonary arterial hypertension: A meta-analysis of 15 cohort studies
Xinwang Chen, Zhenguo Zhai, Lan Lin, Dan Xue, Xiangqi Chen, Hong Zhang, Qiong Lin
Thrombosis Research.2024; 243: 109173. CrossRef Effects of oral anticoagulant therapy in patients with pulmonary diseases
Jiying Lai, Shenghui Feng, Shuo Xu, Xin Liu
Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef Can anticoagulants improve the survival rate for patients with idiopathic pulmonary arterial hypertension? A systematic review and meta-analysis
Peijie Wang, Liu Hu, Yin Yin, Dongqing Yan, Hongjie Zheng, Junhang Zhang, Yun Li
Thrombosis Research.2020; 196: 251. CrossRef Therapy for Pulmonary Arterial Hypertension in Adults
James R. Klinger, C. Gregory Elliott, Deborah J. Levine, Eduardo Bossone, Laura Duvall, Karen Fagan, Julie Frantsve-Hawley, Steven M. Kawut, John J. Ryan, Erika B. Rosenzweig, Nneka Sederstrom, Virginia D. Steen, David B. Badesch
Chest.2019; 155(3): 565. CrossRef Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?
Muhammad Shahzeb Khan, Muhammad Shariq Usman, Tariq Jamal Siddiqi, Safi U. Khan, M. Hassan Murad, Farouk Mookadam, Vincent M. Figueredo, Richard A. Krasuski, Raymond L. Benza, Jonathan D. Rich
Circulation: Cardiovascular Quality and Outcomes.2018;[Epub] CrossRef
|